Precision
Biologics
Premium human and animal serum, plasma, and custom biofluids — ethically sourced, rigorously tested, and backed by uncompromising quality standards.
The Gold Standard in Biological Reference Materials
Specibio, a brand of Celltech Discovery Solutions, delivers premium-grade human and animal biological specimens to research institutions, diagnostic developers, and pharmaceutical organisations worldwide.
From normal donor serum and plasma to complex disease-state biofluids, every specimen we supply is collected under rigorous ethical frameworks, processed under GLP-compliant conditions, and comprehensively characterised to support your most demanding applications.
Comprehensive Biofluid Solutions
Can't Find What You Need?
Our scientific team specialises in bespoke biofluid procurement. Tell us your specifications and we will design a collection protocol for your exact research requirements.
Product Catalogue
Two primary categories — Human Biofluids and Animal Biofluids — each covering whole blood, serum, plasma, and specialised specimens. Available from inventory or via bespoke collection protocols.
Unfractionated human whole blood collected from healthy prescreened donors or confirmed disease-state subjects. Combined with anticoagulant at point of collection. Available fresh (same-day) or cryopreserved. All units tested for mandatory viral markers.
| Product | Anticoagulant | Donor Status | Volume Options | Notes |
|---|---|---|---|---|
| Human Whole Blood — K2EDTA | K2EDTA 1.8 mg/mL | Healthy | 1 • 5 • 10 • 50 mL | Standard; CBC compatible; fresh or frozen |
| Human Whole Blood — Lithium Heparin | Li-Heparin 15 IU/mL | Healthy | 1 • 5 • 10 • 50 mL | Biochemistry & flow cytometry applications |
| Human Whole Blood — Sodium Citrate 3.2% | Sodium Citrate 3.2% | Healthy | 1 • 5 • 10 mL | Coagulation studies; PT/APTT compatible |
| Human Whole Blood — ACD Formula A | ACD-A | Healthy | 1 • 5 • 10 mL | Red cell & platelet function studies |
| Human Whole Blood — Disease State | K2EDTA • Li-Hep • Citrate | Disease State | 1 • 5 mL | 50+ confirmed conditions; clinical metadata included |
Off-the-clot serum from healthy screened donors across all ABO/Rh blood groups. Every lot tested negative for the full mandatory viral panel (HBsAg, HIV-1/2, HCV, HBV NAT, HTLV-I/II, syphilis, WNV). Single-donor or multi-donor pooled formats.
| Product | Blood Group | Donor Profile | Volume Options | Testing Included |
|---|---|---|---|---|
| Normal Human Serum — Mixed Pool | Mixed / Pooled | HealthyMixed Sex | 0.5 • 1 • 5 • 10 • 50 mL | Full viral panel • Sterility • Mycoplasma |
| Normal Human Serum — A Rh+ | A+ | Healthy | 0.5 • 1 • 5 • 10 mL | Full viral panel • Sterility |
| Normal Human Serum — B Rh+ | B+ | Healthy | 0.5 • 1 • 5 • 10 mL | Full viral panel • Sterility |
| Normal Human Serum — AB Rh+ | AB+ | Healthy | 0.5 • 1 • 5 • 10 mL | Full viral panel • Sterility |
| Normal Human Serum — O Rh+ | O+ | Healthy | 0.5 • 1 • 5 • 10 mL | Full viral panel • Sterility |
| Normal Human Serum — O Rh− (Universal) | O− | Healthy | 0.5 • 1 • 5 mL | Full viral panel • Sterility |
| Human AB Serum — Male Donors, Pooled | AB (Male only) | HealthyMale | 5 • 10 • 50 • 100 mL | Full viral panel • Endotoxin • Mycoplasma • Sterility |
| Human Serum — Female Donors Only | Mixed (Female) | HealthyFemale | 0.5 • 1 • 5 • 10 mL | Full viral panel • Sterility |
| Cord Blood Serum (Neonatal) | Cord / Neonatal | Neonatal | 0.5 • 1 mL | Full viral panel • Sterility |
| Disease-State Human Serum | All groups available | Disease State | 0.5 • 1 • 5 mL | Full viral panel • Disease-specific biomarkers; 50+ conditions |
Human plasma collected with a full range of anticoagulants from healthy, virally-tested donors. Processed within 24 hours of collection and stored at −80°C. Available individually or in large pooled formats for assay development and IVD kit manufacturing.
| Product | Anticoagulant | Format | Volume Options | Primary Application |
|---|---|---|---|---|
| Human Plasma — K2EDTA | K2EDTA 1.8 mg/mL | SinglePooled | 0.5 • 1 • 5 • 10 • 50 mL | Standard for most assays; inhibits complement |
| Human Plasma — K3EDTA | K3EDTA spray-dried | SinglePooled | 0.5 • 1 • 5 • 10 mL | Haematological applications |
| Human Plasma — Lithium Heparin | Li-Heparin 15 IU/mL | SinglePooled | 0.5 • 1 • 5 • 10 • 50 mL | Biochemistry; not for coagulation assays |
| Human Plasma — Sodium Heparin | Na-Heparin | SinglePooled | 0.5 • 1 • 5 • 10 mL | Flow cytometry applications |
| Human Plasma — Sodium Citrate 3.2% | Sodium Citrate 3.2% | SinglePooled | 0.5 • 1 • 5 • 10 mL | Coagulation testing — PT, APTT, fibrinogen |
| Human Plasma — Sodium Citrate 3.8% | Sodium Citrate 3.8% | SinglePooled | 0.5 • 1 • 5 mL | ESR testing; selected coagulation assays |
| Platelet-Poor Plasma (PPP) — Double Spun | K2EDTA or Li-Heparin | SinglePooled | 0.5 • 1 • 5 mL | <10,000 plt/μL; two-spin protocol |
| Platelet-Rich Plasma (PRP) | ACD-A or Citrate | Single | 0.5 • 1 mL | Custom platelet count on request |
| Human Plasma — ACD Formula A | ACD Formula A | SinglePooled | 0.5 • 1 • 5 • 10 mL | Red cell studies; platelet function |
| Disease-State Human Plasma | K2EDTA • Li-Hep • Citrate | Single donor | 0.5 • 1 • 5 mL | 50+ confirmed conditions; clinical metadata |
Serum and plasma from donors with physician-confirmed diagnoses, with comprehensive clinical metadata supplied. Collected under IRB-approved protocols with full informed consent. Ideal for IVD assay validation, biomarker discovery, and regulatory submissions.
| Disease / Condition | Matrix Available | Clinical Data Included | Format |
|---|---|---|---|
| Type 1 Diabetes (T1DM) | SerumPlasma | HbA1c • Insulin • Diagnosis date • Medications | Single • Pooled |
| Type 2 Diabetes (T2DM) | SerumPlasma | HbA1c • Fasting glucose • BMI • Duration | Single • Pooled |
| Cardiovascular Disease (CVD) | SerumPlasma | Lipid panel • Troponin • Diagnosis type • Treatment | Single • Pooled |
| Acute Myocardial Infarction | SerumPlasma | Troponin I/T • CK-MB • BNP • TIMI score • Time post-event | Single donor |
| Breast Cancer | SerumPlasma | AJCC stage • ER/PR/HER2 • CA 15-3 • Treatment status | Single donor |
| Lung Cancer (NSCLC / SCLC) | SerumPlasma | Stage • Histology • EGFR/ALK/PD-L1 • Smoking history | Single donor |
| Colorectal Cancer | SerumPlasma | CEA • Stage • MSI/KRAS status • Surgical status | Single donor |
| Prostate Cancer | SerumPlasma | Total & Free PSA • Gleason score • Stage • Treatment | Single donor |
| Hepatocellular Carcinoma | SerumPlasma | AFP • Stage • HBV/HCV status • Liver function | Single donor |
| Rheumatoid Arthritis (RA) | SerumPlasma | RF • Anti-CCP • ESR • CRP • DAS28 • Medications | Single • Pooled |
| Systemic Lupus Erythematosus (SLE) | SerumPlasma | ANA • Anti-dsDNA • Complement C3/C4 • SLEDAI | Single donor |
| Multiple Sclerosis (MS) | SerumPlasma | Type (RRMS/PPMS) • EDSS • Oligoclonal bands • Treatment | Single donor |
| HIV-1 Seropositive | SerumPlasma | Viral load • CD4 count • CD4:CD8 ratio • ARV regimen | Single donor |
| Hepatitis B (HBsAg+) | SerumPlasma | HBsAg titre • HBeAg • ALT • HBV viral load | Single • High-titre pool |
| Hepatitis C (Anti-HCV+) | SerumPlasma | Genotype • HCV viral load • ALT • Treatment status | Single • High-titre pool |
| Chronic Kidney Disease (CKD) | SerumPlasma | eGFR • Creatinine • BUN • Cystatin C • CKD stage | Single • Pooled |
| Thyroid Disorders (Hypo / Hyper) | Serum | TSH • Free T3 • Free T4 • Anti-TPO • Anti-Tg | Single • Pooled |
| Pregnancy (Trimester-Specific) | SerumPlasma | Gestational week • hCG • AFP • PAPP-A • Screening markers | Single donor |
| Sepsis / Systemic Infection | SerumPlasma | CRP • PCT • Lactate • Organism • SOFA/APACHE II | Single donor |
Additional disease states and rare conditions available on request. All samples include a full Certificate of Analysis with clinical metadata.
Biofluids beyond blood — collected under IRB-approved protocols, processed to defined specifications, and stored under validated conditions. Available from healthy donors and disease-state subjects. Paired collections with matched serum/plasma available on request.
| Biofluid | Collection Method | Donor Status | Volume Range | Key Applications |
|---|---|---|---|---|
| Urine | First-void • Mid-stream • 24-hour pooled | HealthyDisease | 1 – 100 mL | Renal biomarkers; drug metabolism; creatinine-normalised |
| Saliva / Oral Fluid | Unstimulated • Stimulated • Swabs | HealthyDisease | 0.5 – 10 mL | Hormone assays; drug testing; paired blood matrix |
| Cerebrospinal Fluid (CSF) | Lumbar puncture | HealthyNeurological | 0.25 – 2 mL | Neurodegeneration — Alzheimer's, MS, Parkinson's |
| Synovial Fluid | Knee or hip joint aspirate | HealthyOARA | 0.5 – 5 mL | Musculoskeletal research; viscosity preserved |
| Bronchoalveolar Lavage (BAL) | Bronchoscopy | HealthyCOPDAsthma | 1 – 10 mL | Respiratory biomarkers; cellular differential available |
| Amniotic Fluid | Amniocentesis (2nd trimester) | NormalCustom | 1 – 5 mL | Prenatal diagnostics; chromosomal data available |
| Pleural / Ascitic Fluid | Thoracentesis • Paracentesis | Disease State | 1 – 20 mL | Oncology; exudate or transudate; aetiology documented |
| Seminal Plasma | Ejaculate, centrifuged | Healthy | 0.5 – 2 mL | Fertility research; semen analysis parameters included |
Whole blood from purpose-bred or production animals, collected under veterinary supervision in compliance with 3Rs principles. Available in standard anticoagulants. Fresh or cryopreserved. Strain, sex, age, and weight can be specified.
| Species | Common Strains / Breeds | Anticoagulants Available | Volumes |
|---|---|---|---|
| Mouse (Mus musculus) | BALB/c • C57BL/6 • CD-1 • NMRI • Swiss | K2EDTA • Li-Heparin • Citrate | 0.1 – 1 mL |
| Rat (Rattus norvegicus) | Sprague-Dawley • Wistar • Fischer 344 • Lewis | K2EDTA • Li-Heparin • Citrate | 0.5 – 5 mL |
| Rabbit (Oryctolagus cuniculus) | New Zealand White • Dutch Belted | K2EDTA • Li-Heparin • Citrate • ACD-A | 1 – 20 mL |
| Guinea Pig (Cavia porcellus) | Dunkin Hartley • Strain 2 • Strain 13 | K2EDTA • Li-Heparin | 0.5 – 5 mL |
| Hamster (Mesocricetus auratus) | Syrian (Golden) • Chinese | K2EDTA • Li-Heparin | 0.1 – 1 mL |
| Bovine (Bos taurus) | Mixed Herd / Friesian | K2EDTA • Li-Heparin • Na-Heparin • Citrate | 10 – 500 mL |
| Ovine / Sheep (Ovis aries) | Merino • Mixed breed | K2EDTA • Li-Heparin • Na-Heparin | 5 – 100 mL |
| Goat (Capra aegagrus hircus) | Mixed breed | K2EDTA • Li-Heparin | 5 – 50 mL |
| Porcine / Swine (Sus scrofa) | Landrace • Large White • Göttingen Minipig | K2EDTA • Li-Heparin • Citrate • ACD-A | 5 – 200 mL |
| Equine / Horse (Equus caballus) | Thoroughbred • Warmblood • Mixed | K2EDTA • Na-Heparin • Citrate | 10 – 500 mL |
| Canine (Canis lupus familiaris) | Beagle • Labrador • Mixed | K2EDTA • Li-Heparin • Citrate • ACD-A | 1 – 50 mL |
| Feline (Felis catus) | Domestic Shorthair • Mixed | K2EDTA • Li-Heparin | 0.5 – 10 mL |
| Non-Human Primate | Cynomolgus • Rhesus Macaque • Marmoset | K2EDTA • Li-Heparin • Na-Heparin | 0.5 – 10 mL |
Off-the-clot serum from 13+ species. Processed within defined time windows under veterinary-supervised collection, centrifuged and aliquoted in cleanroom conditions. Single-donor and pooled formats available. Complement activity, protein profiles, and sterility data available on request.
Animal plasma in EDTA, Heparin, and Citrate formats from all major research species. Processed under defined SOPs with species-appropriate centrifugation protocols. Single-donor, pooled, and large-volume bulk formats available. Age, sex, weight, and strain metadata supplied.
| Species | EDTA Plasma | Heparin Plasma | Citrate Plasma | Volume Options | Notes |
|---|---|---|---|---|---|
| Mouse | K2EDTA | Li-Hep | — | 0.1 – 5 mL (pooled) | Strain-specific; age/sex matched |
| Rat | K2EDTA | Li-Hep | Na-Citrate | 0.5 – 10 mL | Age, sex & strain on request |
| Rabbit | K2EDTA | Li-Hep | Na-Citrate 3.2% | 1 – 50 mL | Complement and coagulation studies |
| Guinea Pig | K2EDTA | Li-Hep | — | 0.5 – 5 mL | Complement-rich; haemolytic assays |
| Hamster | K2EDTA | Li-Hep | — | 0.1 – 2 mL | Pooled format available |
| Bovine | K2EDTA | Na-Hep | Na-Citrate | 10 – 500 mL | Gamma-irradiated available; bulk supply |
| Ovine / Sheep | K2EDTA | Na-Hep | — | 5 – 100 mL | Haematology controls; immunology |
| Goat | K2EDTA | Li-Hep | — | 5 – 50 mL | Immunoassay blocking |
| Porcine / Swine | K2EDTA | Li-Hep | Na-Citrate | 5 – 200 mL | Cardiovascular model; Minipig option |
| Equine / Horse | K2EDTA | Na-Hep | Na-Citrate | 10 – 500 mL | Large-volume bulk production |
| Canine | K2EDTA | Li-Hep | Na-Citrate 3.2% | 1 – 50 mL | Toxicology; pre-/post-dose paired |
| Feline | K2EDTA | Li-Hep | — | 0.5 – 10 mL | Veterinary diagnostics |
| Non-Human Primate | K2EDTA | Na-HepLi-Hep | — | 0.5 – 10 mL | CITES & import documentation provided |
Ethics in Collection
Our commitment to ethical biospecimen procurement is foundational to everything we do. Every sample we provide is collected with the highest standards of donor welfare, informed consent, and regulatory compliance.
Ethical Sourcing Is Not Optional — It Is Foundational
At Specibio, we believe that the integrity of biological research begins with how specimens are obtained. Our procurement practices are guided by internationally recognised ethical frameworks and enforced through rigorous internal governance. We do not simply meet the minimum requirements — we set a higher standard.
Informed Donor Consent
Every human biospecimen in our catalogue is collected with the full, freely given, and documented informed consent of the donor. Donors are provided with a clear explanation of how their samples will be used, their right to withdraw without consequence, and the privacy measures protecting their identity. Consent is obtained by trained clinical staff at licensed collection facilities, in compliance with applicable local law and ICH-GCP requirements.
Institutional Review Board (IRB) Oversight
All human biospecimen collections are conducted under IRB-approved protocols, in compliance with the U.S. Code of Federal Regulations (45 CFR Part 46), FDA 21 CFR requirements, and equivalent regulatory standards in all operating jurisdictions. Protocols are reviewed and renewed on schedule. All amendments are submitted for IRB approval before implementation. End users may request IRB protocol numbers and relevant ethical approval documentation.
Donor Privacy & Confidentiality
Donor identity is never disclosed to end users. All specimens are de-identified and tracked solely by barcode. Clinical metadata is provided in anonymised, non-traceable format in compliance with HIPAA and international data protection frameworks including GDPR. To maintain donor confidentiality and prevent sampling bias, no personally identifiable information is ever included in product documentation.
Equitable & Fair Compensation
Donors receive compensation that is appropriate and fair, and that does not constitute undue inducement as defined under applicable ethical guidelines. We maintain a strict separation between compensation for inconvenience and reimbursement of expenses. Our practices are designed to prevent exploitation of economically vulnerable populations and are reviewed regularly against CIOMS guidelines.
International Ethical Frameworks
Our collection practices align with the foundational documents of biomedical research ethics:
- Nuremberg Code (1947) — foundational principles of voluntary consent in research
- Declaration of Helsinki (2013) — WMA principles for medical research involving human subjects
- The Belmont Report — respect for persons, beneficence, and justice in research
- CIOMS International Ethical Guidelines — for health-related research with human participants
- Nuffield Council on Bioethics — guidance on ethics of human biological collections
- Good Clinical Practice (ICH-GCP E6) — internationally accepted standard for all clinical collection activities
Animal Welfare — The 3Rs Principle
All animal-derived specimens are obtained in strict accordance with the 3Rs framework, endorsed by the NC3Rs and regulatory authorities worldwide:
- Replace — We prioritise in-vitro and other non-animal alternative methodologies wherever scientifically valid, actively reducing dependence on animal models
- Reduce — Collection procedures are optimised to obtain maximum scientific value from the minimum number of animals, using statistical design to avoid excess
- Refine — All collection procedures use the least invasive techniques possible. Animal welfare is continuously monitored by qualified veterinary professionals, with defined endpoints and minimisation of suffering
Traceability & Transparency
We maintain complete documentation of the chain of custody for every specimen from the point of collection to final shipment. Pharmaceutical and diagnostic customers may request proof of ethical collection, IRB protocol numbers, and consent language in redacted form to support regulatory submissions. We believe that transparency in biospecimen provenance is an essential element of research integrity, and that knowing the source of specimens strengthens — rather than undermines — data protection.
Quality Control
Uncompromising quality at every step — from donor screening and sterile collection to processing, independent testing, cold-chain storage, and documented delivery. Every Specibio product is backed by a full Certificate of Analysis.
End-to-End Quality Assurance
Every sample in our catalogue passes through a defined, documented quality management workflow. Our processes are built on GLP principles and we maintain full, unbroken traceability from donor to end user.
Standard Testing Panels
Human Biospecimen — Viral Safety Panel
All Human ProductsMicrobial Safety & Product Quality
Selected Products / On RequestClinical Chemistry & Characterisation
Disease-State & Custom ProductsCustom Request & Contact
Describe your requirements and our scientific team will design a collection protocol to your exact specifications — unique donor demographics, rare disease states, custom volumes, or complex study designs.
Submit a Custom Biofluid Request
Complete the form below and a member of our scientific team will respond within one business day with a feasibility assessment and indicative pricing.
Get in Touch
Specibio Division
2 — Donor availability & protocol feasibility confirmed
3 — Detailed proposal within 24–48 hours
4 — On approval, collection is initiated
5 — Samples shipped with full CoA documentation
Why Choose a Custom Collection?
- Exact donor demographics and inclusion/exclusion criteria to your protocol
- Confirmed disease states with verified, comprehensive clinical data
- Bespoke processing protocols and anticoagulant selection
- Longitudinal sampling from the same matched donor cohort
- Paired samples (pre/post treatment, disease/healthy control)
- Study-specific consent language for IND and 510(k) submissions
- Scalable volume — from pilot quantities to large-lot manufacturing supply